Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024 2024-08-05
DATE OF BOARD MEETING 2024-08-02
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024 2024-07-05
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 12, 2024 2024-06-12
VOLUNTARY ANNOUNCEMENT – COLLABORATION WITH ARRIVENT IN RELATION TO THE RESEARCH, DEVELOPMENT AND COMMERCIALIZATION OF ADC PRODUCTS 2024-06-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024 2024-06-03
VOLUNTARY ANNOUNCEMENT – RESEARCH UPDATES ON A PHASE I/II CLINICAL STUDY OF JSKN003 FOR THE TREATMENT OF ADVANCED SOLID TUMORS FOR PRESENTATION AT 2024 ASCO ANNUAL MEETING 2024-06-03
INSIDE INFORMATION ANNOUNCEMENT – UPDATES IN RELATION TO A PHASE III CLINICAL TRIAL OF KN046 FOR THE TREATMENT OF ADVANCED PDAC 2024-05-28
Next Day Disclosure Return 2024-05-28
VOLUNTARY ANNOUNCEMENT – FIRST PATIENT DOSED IN A PHASE I CLINICAL TRIAL OF JSKN016 FOR THE TREATMENT OF ADVANCED MALIGNANT SOLID TUMORS 2024-05-21